← Back to Search

Kōmmour Prenatal for Prenatal Health Disparities among Marshallese Pregnant Women

N/A

Recruiting

Led By Britni Ayers, PhD

Research Sponsored by University of Arkansas

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

The inclusion criteria are: (1) women who self-report as Marshallese, and (2) 18 years of age or older, and (3) 8-20 weeks pregnant

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 9 months

Awards & highlights

Study Summary

This trial will study whether a culturally-adapted prenatal program can reduce maternal and infant health disparities among Marshallese Pacific Islander women in the US.

Who is the study for?

This trial is for Marshallese women who are at least 18 years old and between 8-20 weeks pregnant. It aims to help reduce health issues for mothers and babies by adapting a group prenatal program specifically for their community.Check my eligibility

What is being tested?

The study is testing the Kōmmour Prenatal program, which has been culturally tailored for Marshallese Pacific Islander women in the US. The focus is on its feasibility and effectiveness in improving maternal and infant health outcomes.See study design

What are the potential side effects?

Since this trial involves a prenatal care program rather than medication, there aren't typical drug side effects. However, participants may experience changes related to new healthcare practices or adjustments to the cultural aspects of the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 9 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~9 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Gestational Weight Gain

Secondary outcome measures

Breastfeeding initiation, birth weight of infant, preeclampsia, primary cesarean birth, and gestational diabetes mellitus

Trial Design

1Treatment groups

Experimental Treatment

Group I: Kōmmour PrenatalExperimental Treatment1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor

486 Previous Clinical Trials

150,313 Total Patients Enrolled

Britni Ayers, PhDPrincipal InvestigatorUniversity of Arkansas for Medical Sciences Northwest

Media Library

Kōmmour Prenatal Clinical Trial Eligibility Overview. Trial Name: NCT04558619 — N/A

Kōmmour Prenatal Among Marshallese Pregnant Women Research Study Groups: Kōmmour Prenatal

Kōmmour Prenatal Among Marshallese Pregnant Women Clinical Trial 2023: Kōmmour Prenatal Highlights & Side Effects. Trial Name: NCT04558619 — N/A

Kōmmour Prenatal 2023 Treatment Timeline for Medical Study. Trial Name: NCT04558619 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment process for this experiment ongoing?

"Correct. The clinical trial directory on clinicaltrials.gov reveals that this research is actively recruiting patients; it was first posted in April 5th 2022 and recently updated on May 10th of the same year, with 40 participants needed at a single site."

Answered by AI

How many participants are being accepted for this clinical trial?

"Affirmative. The information hosted on clinicaltrials.gov indicates that this trial is still searching for patients; it was first posted in April of 2022 and edited most recently in May 2022. 40 participants are targeted to be enrolled from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Exploring the Feasibility of Kōmmour Prenatal to Reduce Maternal and Infant Health Disparities

2022. "Exploring the Feasibility of Kōmmour Prenatal to Reduce Maternal and Infant Health Disparities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04558619.